Explainer6 min read
Do GLP-1 patches work? What they contain and what the evidence says
No FDA-approved GLP-1 patch exists. Here is why GLP-1 drugs cannot pass through skin from a sticker, what patch ingredients have been tested by mouth, and how to read patch reviews.
By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified
The short answer: no, GLP-1 patches do not deliver a GLP-1 drug, and there is no FDA-approved GLP-1 patch. The approved GLP-1 drugs for weight management, tirzepatide and semaglutide, are given by injection, and semaglutide is also approved as a daily tablet. [1] [2] Patches sold under the GLP-1 name use the term as marketing. Whatever they contain, no published human trial shows that any of them causes meaningful weight loss.
This explainer covers why skin blocks GLP-1 drugs, what the ingredients these patches tend to name have shown when taken by mouth, and how to read the reviews. We do not name patch products or their makers.
Is there an FDA-approved GLP-1 patch?
No. The approved GLP-1 drugs for weight management come as subcutaneous injections, plus semaglutide tablets. [1] [2] No patch, cream, or other skin form of semaglutide, tirzepatide, or any other GLP-1 receptor agonist has been approved. Every approval date and label change for semaglutide is on its regulatory tracker.
Do GLP-1 patches work?
A patch can only work if its active ingredient crosses the skin in a useful amount and then does something in the body. GLP-1 drugs fail the first test.
Tirzepatide is a peptide with a molecular weight of 4,813.53 daltons. [1] Human skin is a strong barrier, and a widely cited dermatology analysis argues that a compound generally needs a molecular weight under 500 daltons to pass through intact skin; every topical drug in transdermal delivery systems at the time met that limit. [3] A GLP-1 peptide is roughly ten times too large to soak in from an adhesive sticker.
Researchers are working on ways around that barrier, mainly microneedles, tiny projections that pierce the outer layer of skin. A 2025 study in mice found that a lab-built transdermal system delivering semaglutide lowered body weight. [4] Another 2025 study reported preclinical testing of hyaluronic acid microneedles loaded with semaglutide. [5] Both are animal and laboratory work. They show the delivery problem is being studied, not that any consumer patch solves it, and they involve the real drug, which no consumer patch contains.
What is actually in a GLP-1 patch?
Legally, a patch is not a dietary supplement. FDA defines a dietary supplement as a product intended for ingestion, so something applied to the skin does not fit the category. [6] A skin product is a cosmetic if it is meant to cleanse or beautify, and a drug if it is intended to affect the structure or function of the body, such as appetite or weight. [7] A patch sold to curb appetite or cause weight loss is making a drug claim without an approval.
When these patches list ingredients at all, the names usually match the botanicals and minerals sold in "GLP-1 booster" capsules. Ingredient lists on unregulated products are not verified, so treat any label as a claim.
What do patch ingredients show when taken by mouth?
Some of the ingredients these products name have been studied, but as oral supplements. None of the trials below tested skin delivery.
- Berberine. A 2020 meta-analysis of 12 randomized trials found that oral berberine lowered body weight by an average of 2.07 kg. [8] A 2022 meta-analysis of 37 trials in type 2 diabetes found an average HbA1c reduction of 0.63 percentage points. [9] That is a real but modest effect, by mouth, at supplement doses.
- Green tea extract. A Cochrane review found that green tea preparations produced a small, statistically non-significant weight loss in adults with overweight or obesity. [10]
- Chromium. A Cochrane review of chromium picolinate found an effect of about 1.1 kg of debatable clinical relevance, based on low-quality evidence, and concluded there was no reliable evidence to guide decisions. [11]
Across the field, a systematic review of 315 randomized trials of weight loss supplements and alternative therapies found that only 52 were low risk of bias with sufficient data, and only 16 of those showed a significant weight difference, ranging from 0.3 to 4.93 kg. [12]
GLP-1 patches vs GLP-1 drugs
Compare those numbers with the approved drugs. In SURMOUNT-1, tirzepatide 15 mg produced a mean weight change of minus 20.9% at 72 weeks, versus minus 3.1% on placebo. [13] In STEP 1, semaglutide 2.4 mg produced minus 14.9% at 68 weeks, versus minus 2.4%. [14] For a person weighing 100 kg, that is roughly 15 to 21 kg on the drugs versus about 2 kg for the best-studied supplement ingredient, taken by mouth. Our semaglutide vs tirzepatide comparison covers how the two drugs differ, and the obesity condition page grades every option.
Are GLP-1 patch reviews trustworthy?
Search results for these patches are full of star ratings and before-and-after stories. None of that is evidence the product works. The Federal Trade Commission expects health claims to be supported by competent and reliable scientific evidence, generally well-designed human trials, and says consumer testimonials do not substitute for that. [15] A fair test of a patch would be a randomized, placebo-controlled trial of that exact product. We found none.
Why some people report results on a patch
Stories of weight loss on a patch are not proof the patch did it. People who buy a weight loss product often change what they eat or how much they move at the same time. Placebo arms in drug trials show how much that alone can do: in SURMOUNT-1, participants on placebo, who also received lifestyle counseling, lost a mean 3.1% of body weight over 72 weeks. [13] Without a placebo group, there is no way to separate a patch from the diet, the attention, or ordinary week-to-week variation on the scale. That is exactly why randomized trials exist, and why none of these products can point to one.
Safety: what can go wrong
The main risk of a sticker with plant extracts is wasted money and delayed care. There are larger risks in the same market. FDA has repeatedly found products marketed for weight loss that contain hidden drug ingredients, and warns that they can cause serious harm. [16] FDA has also warned about unapproved GLP-1 products sold online, including items labeled for research use, which may contain the wrong ingredient, too much, too little, or none. [17] A product that claims to contain an actual GLP-1 drug in a patch or drops, sold without a prescription, is in that category.
What to do instead
If weight is a medical concern, the options with trial evidence are prescription drugs, used with a licensed prescriber. Prices have dropped: see semaglutide cost and tirzepatide cost for list, cash, and insurance prices. If you are weighing supplements, our GLP-1 supplements explainer grades each "booster" ingredient. For the lawful way to get a prescription, see how to get peptides prescribed, the GLP-1 hub, and our state legal guides.
Decisions about starting, stopping, or combining any treatment belong with a licensed clinician who knows your history.
Pages referenced in this article
- PeptideSemaglutide
- PeptideTirzepatide
- ComparisonSemaglutide vs tirzepatide
- ConditionObesity and chronic weight management
- CostSemaglutide cost
- CostTirzepatide cost
- RegulatorySemaglutide regulatory timeline
- IndexState legal guides
Frequently asked questions
Is there an FDA-approved GLP-1 patch?
No. The approved GLP-1 drugs for weight management are given by subcutaneous injection, and semaglutide is also approved as a once-daily tablet. No patch form of any GLP-1 drug is approved. [1] [2]
Can a GLP-1 drug be absorbed through the skin from a patch?
Not from an ordinary adhesive patch. Tirzepatide has a molecular weight of about 4,814 daltons, and passive skin absorption is generally limited to molecules under about 500 daltons. Researchers are testing microneedle systems that pierce the outer skin layer, but that work is still in animals. [1] [3] [4] [5]
Do GLP-1 patch ingredients like berberine work?
Berberine taken by mouth has randomized trials: a 2020 meta-analysis found an average weight reduction of about 2.1 kg. We found no published human trial of berberine absorbed through the skin, and no trial of any GLP-1 patch product. [8]
Is a GLP-1 patch a dietary supplement?
No. FDA defines a dietary supplement as a product intended for ingestion, so a patch applied to the skin is not one. A skin product marketed to change appetite or body weight is making a drug claim, and no GLP-1 patch has drug approval. [6] [7]
Are GLP-1 patch reviews reliable?
Reviews are not evidence. Federal advertising rules expect health claims to be backed by competent and reliable scientific evidence, and testimonials do not meet that bar. Look for a randomized trial of the exact product, which none of these patches has. [15]
Sources
Numbered citations in the article point to these primary sources. PubMed entries link to the indexed abstract. Evidence grades follow our methodology.
- [1]FDA prescribing information for Zepbound (tirzepatide) injection, via DailyMed (description and dosage forms)FDA
- [2]FDA prescribing information for Wegovy (semaglutide) injection and tablets, via DailyMedFDA
- [3]Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000PubMed 10839713, 2000
- [4]Li W et al. Transdermal semaglutide administration in mice: reduces body weight by suppressing appetite and enhancing metabolic rate. Biology (Basel) 2025PubMed 40427764, 2025
- [5]Woo CR et al. Fabrication and preclinical evaluation of hyaluronic acid/aminoclay nanocomposite microneedles for noninvasive delivery of semaglutide in anti-obesity therapy. Int J Nanomedicine 2025PubMed 41030572, 2025
- [6]FDA: Questions and answers on dietary supplements (definition, premarket approval, and disease claims)FDA
- [7]FDA: Is it a cosmetic, a drug, or both? (or is it soap?)FDA
- [8]Asbaghi O et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN 2020PubMed 32690176, 2020
- [9]Xie W et al. Glucose-lowering effect of berberine on type 2 diabetes: a systematic review and meta-analysis. Front Pharmacol 2022PubMed 36467075, 2022
- [10]Jurgens TM et al. Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database Syst Rev 2012PubMed 23235664, 2012